Arcturus Therapeutics Holdings, Inc. (ARCT)
6.23
+0.07
(+1.14%)
USD |
NASDAQ |
Dec 30, 10:23
Arcturus Therapeutics Holdings EPS Diluted (Quarterly): -0.4946 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Inovio Pharmaceuticals, Inc. | -0.8721 |
| Perspective Therapeutics, Inc. | -0.3495 |
| Novavax, Inc. | -1.246 |
| Sangamo Therapeutics, Inc. | -0.1148 |
| Myomo, Inc. | -0.0869 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -13.45M |
| Revenue (Quarterly) | 14.15M |
| Total Expenses (Quarterly) | 27.60M |
| Enterprise Value | -34.35M |
| Gross Profit Margin (Quarterly) | 94.35% |
| Profit Margin (Quarterly) | -95.02% |
| Earnings Yield | -39.54% |
| Normalized Earnings Yield | -27.55 |